Skip to content

ANTARES PHARMA, INC.

CIK 0001016169

← back to feed
Revenue (TTM)
$176.81M
+316.9% YoY Q1 May 2022
Net Income (TTM)
$11.29M
−9.9% YoY Q1 May 2022
EPS Diluted (TTM)
$0.07
−21.2% YoY Q1 May 2022
Gross Margin
46.8%
Q1 May 2022
Operating Margin
9.8%
Q1 May 2022
Net Margin
6.4%
Q1 May 2022
Free Cash Flow (TTM)
−$11.61M
Q1 May 2022
Cash
$61.72M
Q1 May 2022
Total Debt
$19.39M
Q1 May 2022
Shares Outstanding
170.85M sh
Q1 May 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings